Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01943422
Title Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors John Kirkwood
Indications

melanoma

Therapies

Interferon alpha-2b + Vemurafenib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST